Trump to meet pharma leaders as they seek drug policy changes
U.S. President Donald Trump will meet on Thursday with chief executives from major drugmakers, a White House official ...
NerdWallet14d
Free Budget Templates and Spreadsheets
These free online tools let you skip the setup and start tracking your money right away. Many, or all, of the products featured on this page are from our advertising partners who compensate us ...
Deltaplex News14d
Pharmacy Benefit Manager Bill Faces Crucial Committee Review
This is the second of two stories about legislation dealing with pharmacy benefit managers and the effects ... Stice said a bill introduced in the State House of Representatives will go to committee ...
Monash University17d
Phrenix secures major funding boost from US and Australian venture capital firms to advance new therapeutics for psychiatric disorders
Phrenix Therapeutics, a cutting-edge biotech company focused on next-generation medicines for psychiatric and neurological disorders, has secured significant seed investment from specialist biotech ...
Frontiers17d
Pathogenesis and novel therapeutics of regulatory T cell subsets and interleukin-2 therapy in systemic lupus erythematosus
This review focuses on the pathogenesis and new therapeutics of human Treg subsets and low-dose IL-2 therapy in clinical benefits with SLE.
Investing21d
Artiva Biotherapeutics appoints new director and committee members
SAN DIEGO – Artiva Biotherapeutics, Inc. (ARTV), a biopharmaceutical company specializing in cellular immunotherapies with a current market capitalization of $135 million, has announced the ...
UCL21d
Next-Gen 3D Printing for Scientific Research and Therapeutics
The Hilton group at UCL School of Pharmacy is pioneering low-cost 3D-printed flow reactors, laboratory equipment, and catalytically active stirrer beads to enhance accessibility and sustainability in ...
Investing22d
Artiva Biotherapeutics appoints new director and committee members
SAN DIEGO – Artiva Biotherapeutics, Inc. (ARTV), a biopharmaceutical company specializing in cellular immunotherapies with a current market capitalization of $135 million, has announced the ...